Multidisciplinary treatment of primary Ewing's sarcoma of bone. A 6‐year experience of a European cooperative trial

Cancer

Volumn 61, Issue 1, 1988, Pages 23-32

  Jürgens, Herbert ^a   Exner, Ulrich ^a   Gadner, Helmut ^b   Harms, Dieter ^c   Michaelis, JÖRg ^d   Sauer, Rolf ^e   Treuner, JÖRn ^f   Voûte, Tom ^g   Winkelmann, Winfried ^h   Winkler, Kurt ⁱ   Göbel, Ulrich ⁱ  

^a BALGRIST UNIVERSITY HOSPITAL   (Switzerland)

^b ST ANNA CHILDREN S HOSPITAL   (Austria)

^c UNIVERSITY OF KIEL   (Germany)

^d JOHANNES GUTENBERG UNIVERSITY   (Germany)

^e UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^f Emma Kinderziekenhuis ^*  (Germany)

^g EMMA CHILDREN S HOSPITAL   (Netherlands)

^h University Department of Orthopedics   (Germany)

ⁱ UNIVERSITY HOSPITAL DÜSSELDORF   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; DACTINOMYCIN; DOXORUBICIN; VINCRISTINE;

BONE CANCER; EWING SARCOMA; HISTOLOGY; HUMAN; MAJOR CLINICAL STUDY;

ADOLESCENT; ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BONE NEOPLASMS; CHILD; CHILD, PRESCHOOL; FEMALE; HUMAN; MALE; NEOPLASM METASTASIS; REGRESSION ANALYSIS; SARCOMA, EWING'S; SUPPORT, NON-U.S. GOV'T;

EID: 0023833536     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/1097-0142(19880101)61:1<23::AID-CNCR2820610106>3.0.CO;2-M     Document Type: Article

References (42)

1. Die Ewingtumoren oder Omoblastome des Knochens: Differentialdiagnostische und kritische Erörterungen
2. Five‐year survival of patients with Ewing's sarcoma
3. The curability of Ewing's endothelioma of bone in children
4. Multimodal therapy for the management of primary non‐metastatic Ewing's sarcoma of bone: An intergroup study
5. Curability of Ewing's sarcoma and considerations for future therapeutic trials
6. Localized Ewing's sarcoma: Results of integrated therapy and analysis of failures
7. Intensive systemic chemotherapy in localized Ewing's sarcoma in childhood: A historical trial
8. Traitement du sarcome d'Ewing par chimiotherapie initiate intensive
9. Analysis of local tumor control in Ewing's sarcoma: Preliminary results of a cooperative inter‐group study
10. Intergroup Ewing's sarcoma study: Local control related to radiation dose, volume and site of primary lesion in Ewing's sarcoma
11. Ewing's sarcoma
12. A story of continuing success: Radiotherapy for Ewing's sarcoma
13. Disease‐free survival in children with Ewing's sarcoma treated with radiation therapy and adjuvant four‐drug sequential chemotherapy
14. Ewing's sarcoma; Ten year experience with adjuvant chemotherapy
15. Conbination chemotherapy (T‐6) in the multidisciplinary treatment of Ewing's sarcoma
16. Problems of local recurrence in patients with Ewing's sarcoma
17. Ewing's sarcoma of bone: Experience with 140 patients
18. Chemotherapeutic induction of remission in Ewing's sarcoma (ES) (Abstr #596)
19. The response to initial chemotherapy as a prognostic factor in localized Ewing's sarcoma
20. Ewing‐Sarkom bei Kindern und Jugendlichen: Planung einer kooperativen Therapiestudie der Gesellschaft für pädiatrische Onkologie (CESS 81)
21. Die Cooperative Ewing‐Sarkom Studie (CESS 81) der GPO: Zwischenbericht
22. The prognostic significance of tumor size in localized Ewing's sarcoma of bone in children and adolescents
23. Morphological grades of regression on osteosarcoma after polychemotherapy: Study COSS 80
24. Ewing‐Sarkom: Lokalrezidive in Abhängigkeit von der Primärtherapie
25. Die Cooperative Ewing‐Sarkom Studie CESS 81 der GPO: Analyse nach 4 Jahren
26. Nonparametric estimation from incomplete observations
27. Regression models and life‐tables (with discussion)
28. Blutbild, Infektionen und supportive Therapie während der Chemotherapie solider Tumoren nach dem T2 und T6 Protokoll
29. Radiation therapy in the multimodal management of Ewing's sarcoma of bone: Report of the intergroup Ewing's sarcoma study
30. The role of radiation therapy in the management of non‐metastatic Ewing's sarcoma of bone: Report of the Intergroup Ewing's Sarcoma Study
31. The relationship between tumor mass and resistance to chemotherapy
32. A mathematical model for relating the drug sensitivity of tumors to their spontaneous mutation rate
33. The effect of primary tumor size on the prognosis of Ewing's sarcoma (Abstr)
34. The prognostic significance of soft tissue extension in Ewing's sarcoma
35. Local recurrence, rate and sites of metastases, and time to relapse as a function of treatment regimen, size of primary and surgical history in 62 patients presenting with nonmetastatic Ewing's sarcoma of the pelvic bones
36. The response to initial chemotherapy as a prognostic factor in localized Ewing's sarcoma
37. Accelerated fractionation vs. hyperfractionation: Rationales for several treatments per day
38. Unconventional fractionation schemes in radiotherapy